Asymptomatic Cerebral Small Vessel Disease: Insights from Population-Based Studies

키워드

참고문헌 (207)

1. Berkhemer OA, "A randomized trial of intraarterial treatment for acute ischemic stroke", N Engl J Med, 372, pp.11~20 (2015)
2. Campbell BC, "Endovascular therapy for ischemic stroke with perfusion-imaging selection", N Engl J Med, 372, pp.1009~1018 (2015)
3. Jovin TG, "Thrombectomy within 8 hours after symptom onset in ischemic stroke", N Engl J Med, 372, pp.2296~2306 (2015)
4. Saver JL, "Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke", N Engl J Med, 372, pp.2285~2295 (2015)
5. Bracard S, "Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke(THRACE) : a randomised controlled trial", Lancet Neurol, 15, pp.1138~1147 (2016)
6. Charidimou A, "The concept of sporadic cerebral small vessel disease: a road map on key definitions and current concepts", Int J Stroke, 11, pp.6~18 (2016)
7. Pantoni L, "Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges", Lancet Neurol, 9, pp.689~701 (2010)
8. Whitman GT, "A prospective study of cerebral white matter abnormalities in older people with gait dysfunction", Neurology, 57, pp.990~994 (2001)
9. Vermeer SE, "Silent brain infarcts and the risk of dementia and cognitive decline", N Engl J Med, 348, pp.1215~1222 (2003)
10. Vermeer SE, "Silent brain infarcts:a systematic review", Lancet Neurol, 6, pp.611~619 (2007)
11. Russo E, "Cerebral small vessel disease predisposes to temporal lobe epilepsy in spontaneously hypertensive rats", Brain Res Bull, 130, pp.245~250 (2017)
12. de Groot JC, "Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study", Ann Neurol, 47, pp.145~151 (2000)
13. van der Holst HM, "Cerebral small vessel disease and incident parkinsonism: The RUN DMC study", Neurology, 85, pp.1569~1577 (2015)
14. Wardlaw JM, "Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging", Lancet Neurol, 12, pp.483~497 (2013)
15. Søndergaard CB, "Hereditary cerebral small vessel disease and stroke", Clin Neurol Neurosurg, 155, pp.45~57 (2017)
16. Jay Chol Choi, "Genetics of Cerebral Small Vessel Disease", 대한뇌졸중영문학회지, 17(1), pp.7~16 (2015), 대한뇌졸중학회
17. Wermer MJH, "The growing clinical spectrum of cerebral amyloid angiopathy", Curr Opin Neurol, 31, pp.28~35 (2018)
18. Charidimou A, "Emerging concepts in sporadic cerebral amyloid angiopathy", Brain, 140, pp.1829~1850 (2017)
19. Greenberg SM, "Small vessels, big problems", N Engl J Med, 354, pp.1451~1453 (2006)
20. Wardlaw JM, "Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration", Lancet Neurol, 12, pp.822~838 (2013)
21. Price TR, "Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults. The Cardiovascular Health Study", Stroke, 28, pp.1158~1164 (1997)
22. Leary MC, "Annual incidence of first silent stroke in the United States: a preliminary estimate", Cerebrovasc Dis, 16, pp.280~285 (2003)
23. Westover MB, "Estimating cerebral microinfarct burden from autopsy samples", Neurology, 80, pp.1365~1369 (2013)
24. Auriel E, "Estimating total cerebral microinfarct burden from diffusion-weighted imaging", Stroke, 46, pp.2129~2135 (2015)
25. van Veluw SJ, "Detection, risk factors, and functional consequences of cerebral microinfarcts", Lancet Neurol, 16, pp.730~740 (2017)
26. Feng C, "The ‘silence’ of silent brain infarctions may be related to chronic ischemic preconditioning and nonstrategic locations rather than to a small infarction size", Clinics, 68, pp.365~369 (2013)
27. Shi Y, "Update on cerebral small vessel disease: a dynamic whole-brain disease", Stroke Vasc Neurol, 1, pp.83~92 (2016)
28. van Leijsen EMC, "Disease progression and regression in sporadic small vessel disease-insights from neuroimaging", Clin Sci, 131, pp.1191~1206 (2017)
29. Hachinski VC, "Leuko-araiosis", Arch Neurol, 44, pp.21~23 (1987)
30. Pantoni L, "The significance of cerebral white matter abnormalities 100 years after Binswanger’s report: a review", Stroke, 26, pp.1293~1301 (1995)
31. Pantoni L, "Pathogenesis of leukoaraiosis: a review", Stroke, 28, pp.652~659 (1997)
32. Debette S, "The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis", BMJ, 341, pp.c3666~ (2010)
33. Topakian R, "Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis", J Neurol Neurosurg Psychiatry, 81, pp.192~197 (2010)
34. Wardlaw JM, "What are white matter hyperintensities made of? Relevance to vascular cognitive impairment", J Am Heart Assoc, 4, pp.001140~ (2015)
35. Longstreth WT Jr, "Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study", Stroke, 27, pp.1274~1282 (1996)
36. Longstreth WT Jr, "Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study", Stroke, 36, pp.56~61 (2005)
37. de Leeuw FE, "Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study", J Neurol Neurosurg Psychiatry, 70, pp.9~14 (2001)
38. van Dijk EJ, "Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study", Stroke, 39, pp.2712~2719 (2008)
39. Liao D, "Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study", Stroke, 27, pp.2262~2270 (1996)
40. Schmidt R, "MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study", Neurology, 53, pp.132~139 (1999)
41. Schmidt R, "White matter lesion progression, brain atrophy, and cognitive decline: the Austrian Stroke Prevention Study", Ann Neurol, 58, pp.610~616 (2005)
42. Power MC, "Smoking and white matter hyperintensity progression:the ARIC-MRI Study", Neurology, 84, pp.841~848 (2015)
43. Jeerakathil T, "Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study", Stroke, 35, pp.1857~1861 (2004)
44. Debette S, "Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline", Neurology, 77, pp.461~468 (2011)
45. Schmidt R, "Progression of leukoaraiosis and cognition", Stroke, 38, pp.2619~2625 (2007)
46. Bokura H, "Silent brain infarction and subcortical white matter lesions increase the risk of stroke and mortality: a prospective cohort study", J Stroke Cerebrovasc Dis, 15, pp.57~63 (2006)
47. Fried LP, "The Cardiovascular Health Study: design and rationale", Ann Epidemiol, 1, pp.263~276 (1991)
48. Tell GS, "Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study", Ann Epidemiol, 3, pp.358~366 (1993)
49. Price TR, "Assessment of cerebrovascular disease in the Cardiovascular Health Study", Ann Epidemiol, 3, pp.504~507 (1993)
50. Manolio TA, "Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study", Stroke, 25, pp.318~327 (1994)
51. Longstreth WT Jr, "Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study", Arch Neurol, 55, pp.1217~1225 (1998)
52. Bernick C, "Silent MRI infarcts and the risk of future stroke: the Cardiovascular Health Study", Neurology, 57, pp.1222~1229 (2001)
53. Longstreth WT Jr, "Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study", Stroke, 33, pp.2376~2382 (2002)
54. Hofman A, "Determinants of disease and disability in the elderly: the Rotterdam Elderly Study", Eur J Epidemiol, 7, pp.403~422 (1991)
55. van Dijk EJ, "Frequency of white matter lesions and silent lacunar infarcts", J Neural Transm Suppl, 62, pp.25~39 (2002)
56. Vermeer SE, "Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study", Stroke, 33, pp.21~25 (2002)
57. Vernooij MW, "Incidental findings on brain MRI in the general population", N Engl J Med, 357, pp.1821~1828 (2007)
58. Poels MM, "Arterial stiffness and cerebral small vessel disease: the Rotterdam Scan Study", Stroke, 43, pp.2637~2642 (2012)
59. Shepherd J, "The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk", Am J Cardiol, 84, pp.1192~1197 (1999)
60. van den Heuvel DM, "Different progression rates for deep white matter hyperintensities in elderly men and women", Neurology, 63, pp.1699~1701 (2004)
61. The ARIC investigators, "The Atherosclerosis Risk in Communities (ARIC) study: design and objectives", Am J Epidemiol, 129, pp.687~702 (1989)
62. Mosley TH Jr, "Cerebral MRI findings and cognitive functioning: the Atherosclerosis Risk in Communities study", Neurology, 64, pp.2056~2062 (2005)
63. Liao D, "The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study", Neuroepidemiology, 16, pp.149~162 (1997)
64. Gottesman RF, "Blood pressure and white-matter disease progression in a biethnic cohort: Atherosclerosis Risk in Communities (ARIC) study", Stroke, 41, pp.3~8 (2010)
65. Wolma J, "Ethnicity a risk factor? The relation between ethnicity and large- and small-vessel disease in White people, Black people, and Asians within a hospitalbased population", Eur J Neurol, 16, pp.522~527 (2009)
66. Hilal S, "Prevalence, risk factors and consequences of cerebral small vessel diseases: data from three Asian countries", J Neurol Neurosurg Psychiatry, 88, pp.669~674 (2017)
67. Sudre CH, "Cardiovascular risk factors and white matter hyperintensities:difference in susceptibility in south Asians compared with Europeans", J Am Heart Assoc, 7, pp.e010533~ (2018)
68. Fei Han, "Prevalence and Risk Factors of Cerebral Small Vessel Disease in a Chinese Population-Based Sample", 대한뇌졸중영문학회지, 20(2), pp.239~246 (2018), 대한뇌졸중학회
69. van Zagten M, "Significant progression of white matter lesions and small deep (lacunar) infarcts in patients with stroke", Arch Neurol, 53, pp.650~655 (1996)
70. Sachdev P, "Progression of white matter hyperintensities in elderly individuals over 3 years", Neurology, 68, pp.214~222 (2007)
71. Wahlund LO, "MRI in successful aging, a 5-year follow-up study from the eighth to ninth decade of life", Magn Reson Imaging, 14, pp.601~608 (1996)
72. Gouw AA, "Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study", Stroke, 39, pp.1414~1420 (2008)
73. Taylor WD, "Serial MR imaging of volumes of hyperintense white matter lesions in elderly patients: correlation with vascular risk factors", AJR Am J Roentgenol, 181, pp.571~576 (2003)
74. Kuller LH, "White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke", Stroke, 35, pp.1821~1825 (2004)
75. Schmidt R, "Risk factors and progression of small vessel disease-related cerebral abnormalities", J Neural Transm Suppl, 62, pp.47~52 (2002)
76. Schmidt R, "Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study", Lancet, 361, pp.2046~2048 (2003)
77. Verhaaren BF, "High blood pressure and cerebral white matter lesion progression in the general population", Hypertension, 61, pp.1354~1359 (2013)
78. Debette S, "Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study", Stroke, 41, pp.600~606 (2010)
79. Ikram MA, "Brain tissue volumes and small vessel disease in relation to the risk of mortality", Neurobiol Aging, 30, pp.450~456 (2009)
80. Kerber KA, "Increased risk of death in community-dwelling older people with white matter hyperintensities on MRI", J Neurol Sci, 250, pp.33~38 (2006)
81. Buyck JF, "Cerebral white matter lesions are associated with the risk of stroke but not with other vascular events: the 3-City Dijon Study", Stroke, 40, pp.2327~2331 (2009)
82. Tully PJ, "White matter lesions are associated with specific depressive symptom trajectories among incident depression and dementia populations:three-city Dijon MRI study", Am J Geriatr Psychiatry, 25, pp.1311~1321 (2017)
83. Smith EE, "Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia", Arch Neurol, 65, pp.94~100 (2008)
84. Silbert LC, "Cognitive impairment risk: white matter hyperintensity progression matters", Neurology, 73, pp.120~125 (2009)
85. van den Heuvel DM, "Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a non-demented elderly population", J Neurol Neurosurg Psychiatry, 77, pp.149~153 (2006)
86. Corder EH, "Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families", Science, 261, pp.921~923 (1993)
87. Heise V, "The APOE ɛ4 allele modulates brain white matter integrity in healthy adults", Mol Psychiatry, 16, pp.908~916 (2011)
88. Sudre CH, "APOE ε4 status is associated with white matter hyperintensities volume accumulation rate independent of AD diagnosis", Neurobiol Aging, 53, pp.67~75 (2017)
89. Cox SR, "Interaction of APOE e4 and poor glycemic control predicts white matter hyperintensity growth from 73 to 76", Neurobiol Aging, 54, pp.54~58 (2017)
90. Prins ND, "Cerebral white matter lesions and the risk of dementia", Arch Neurol, 61, pp.1531~1534 (2004)
91. Fisher CM, "Lacunar strokes and infarcts: a review", Neurology, 32, pp.871~876 (1982)
92. Fisher CM, "Lacunes: small, deep cerebral infarcts", Neurology, 15, pp.774~784 (1965)
93. Kimberly WT, "Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy", Neurology, 72, pp.1230~1235 (2009)
94. Prabhakaran S, "Acute brain infarcts after spontaneous intracerebral hemorrhage: a diffusion-weighted imaging study", Stroke, 41, pp.89~94 (2010)
95. Wardlaw JM, "White matter hyperintensity reduction and outcomes after minor stroke", Neurology, 89, pp.1003~1010 (2017)
96. Moreau F, "Cavitation after acute symptomatic lacunar stroke depends on time, location, and MRI sequence", Stroke, 43, pp.1837~1842 (2012)
97. Fanning JP, "The epidemiology of silent brain infarction: a systematic review of population-based cohorts", BMC Med, 12, pp.119~ (2014)
98. Howard G, "Cigarette smoking and other risk factors for silent cerebral infarction in the general population", Stroke, 29, pp.913~917 (1998)
99. Vermeer SE, "Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study", Stroke, 34, pp.392~396 (2003)
100. Vermeer SE, "Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study", Stroke, 34, pp.1126~1129 (2003)
101. Greenberg SM, "Cerebral microbleeds: a guide to detection and interpretation", Lancet Neurol, 8, pp.165~174 (2009)
102. Martinez-Ramirez S, "Cerebral microbleeds: overview and implications in cognitive impairment", Alzheimers Res Ther, 6, pp.33~ (2014)
103. Shoamanesh A, "Cerebral microbleeds: histopathological correlation of neuroimaging", Cerebrovasc Dis, 32, pp.528~534 (2011)
104. Viswanathan A, "Cerebral microhemorrhage", Stroke, 37, pp.550~555 (2006)
105. Tsushima Y, "MR detection of microhemorrhages in neurologically healthy adults", Neuroradiology, 44, pp.31~36 (2002)
106. Poels MM, "Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study", Stroke, 41, pp.S103~S106 (2010)
107. Roob G, "MRI evidence of past cerebral microbleeds in a healthy elderly population", Neurology, 52, pp.991~994 (1999)
108. Dawber TR, "Epidemiological approaches to heart disease: the Framingham Study", Am J Public Health Nations Health, 41, pp.279~281 (1951)
109. Kannel WB, "An investigation of coronary heart disease in families. The Framingham offspring study", Am J Epidemiol, 110, pp.281~290 (1979)
110. Sveinbjornsdottir S, "Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location", J Neurol Neurosurg Psychiatry, 79, pp.1002~1006 (2008)
111. Del Brutto VJ, "Population-based study of cerebral microbleeds in stroke-free older adults living in rural Ecuador: The Atahualpa Project", Stroke, 46, pp.1984~1986 (2015)
112. de Laat KF, "Microbleeds are independently related to gait disturbances in elderly individuals with cerebral small vessel disease", Stroke, 42, pp.494~497 (2011)
113. Mitaki S, "Serum lipid fractions and cerebral microbleeds in a healthy Japanese population", Cerebrovasc Dis, 43, pp.186~191 (2017)
114. Mok V, "Race-ethnicity and cerebral small vessel disease: comparison between Chinese and White populations", Int J Stroke, 9(Suppl A100), pp.36~42 (2014)
115. Jeerakathil T, "Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study", Stroke, 35, pp.1831~1835 (2004)
116. Vernooij MW, "Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study", Neurology, 70, pp.1208~1214 (2008)
117. Harris TB, "Gene", Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics, 2007, pp.165, 1076~1087
118. Akoudad S, "Cerebral microbleeds are associated with an increased risk of stroke: the Rotterdam Study", Circulation, 132, pp.509~516 (2015)
119. Song TJ, "The distribution of cerebral microbleeds determines their association with arterial stiffness in non-cardioembolic acute stroke patients", Eur J Neurol, 21, pp.463~469 (2014)
120. Vernooij MW, "Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study", Arch Neurol, 66, pp.714~720 (2009)
121. Kakar P, "Cerebral microbleeds: a new dilemma in stroke medicine", JRSM Cardiovasc Dis, 1 (2012)
122. Altmann-Schneider I, "Cerebral microbleeds are predictive of mortality in the elderly", Stroke, 42, pp.638~644 (2011)
123. van Es AC, "Cerebral microbleeds and cognitive functioning in the PROSPER study", Neurology, 77, pp.1446~1452 (2011)
124. Choi P, "Silent infarcts and cerebral microbleeds modify the associations of white matter lesions with gait and postural stability: population-based study", Stroke, 43, pp.1505~1510 (2012)
125. Qiu C, "Cerebral microbleeds, retinopathy, and dementia: the AGES-Reykjavik Study", Neurology, 75, pp.2221~2228 (2010)
126. Akoudad S, "Association of cerebral microbleeds with cognitive decline and dementia", JAMA Neurol, 73, pp.934~943 (2016)
127. Romero JR, "Cerebral microbleeds and risk of incident dementia: the Framingham Heart Study", Neurobiol Aging, 54, pp.94~99 (2017)
128. Weller RO, "Symposium: clearance of Aβ from the brain in Alzheimer’s disease: perivascular drainage of amyloid‐β peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer’s disease", Brain Pathol, 18, pp.253~266 (2008)
129. Charidimou A, "Enlarged perivascular spaces as a marker of underlying arteriopathy in intracerebral haemorrhage: a multicentre MRI cohort study", J Neurol Neurosurg Psychiatry, 84, pp.624~629 (2013)
130. Martinez-Ramirez S, "Topography of dilated perivascular spaces in subjects from a memory clinic cohort", Neurology, 80, pp.1551~1556 (2013)
131. Yakushiji Y, "Topography and associations of perivascular spaces in healthy adults: the Kashima scan study", Neurology, 83, pp.2116~2123 (2014)
132. Zhu YC, "Frequency and location of dilated Virchow-Robin spaces in elderly people: a population-based 3D MR imaging study", AJNR Am J Neuroradiol, 32, pp.709~713 (2011)
133. Ramirez J, "Visible Virchow-Robin spaces on magnetic resonance imaging of Alzheimer’s disease patients and normal elderly from the Sunnybrook Dementia Study", J Alzheimers Dis, 43, pp.415~424 (2015)
134. Zhu YC, "Severity of dilated Virchow-Robin spaces is associated with age, blood pressure, and MRI markers of small vessel disease: a population-based study", Stroke, 41, pp.2483~2490 (2010)
135. Bokura H, "Distinguishing silent lacunar infarction from enlarged Virchow-Robin spaces: a magnetic resonance imaging and pathological study", J Neurol, 245, pp.116~122 (1998)
136. Ding J, "Large perivascular spaces visible on magnetic resonance imaging, cerebral small vessel disease progression, and risk of dementia: the Age, Gene", Environment Susceptibility-Reykjavik Study, 2017, pp.74, 1105~1112
137. Maclullich AM, "Enlarged perivascular spaces are associated with cognitive function in healthy elderly men", J Neurol Neurosurg Psychiatry, 75, pp.1519~1523 (2004)
138. Patankar TF, "Dilatation of the Virchow-Robin space is a sensitive indicator of cerebral microvascular disease: study in elderly patients with dementia", AJNR Am J Neuroradiol, 26, pp.1512~1520 (2005)
139. Arba F, "Enlarged perivascular spaces and cognitive impairment after stroke and transient ischemic attack", Int J Stroke, 13, pp.47~56 (2018)
140. Zhu YC, "High degree of dilated Virchow-Robin spaces on MRI is associated with increased risk of dementia", J Alzheimers Dis, 22, pp.663~672 (2010)
141. Vernooij MW, "Superficial siderosis in the general population", Neurology, 73, pp.202~205 (2009)
142. Charidimou A, "Cortical superficial siderosis: detection and clinical significance in cerebral amyloid angiopathy and related conditions", Brain, 138, pp.2126~2139 (2015)
143. Pichler M, "Prevalence and natural history of superficial siderosis: a population-based study", Stroke, 48, pp.3210~3214 (2017)
144. Roberts RO, "The Mayo Clinic study of aging: design and sampling, participation, baseline measures and sample characteristics", Neuroepidemiology, 30, pp.58~69 (2008)
145. Shoamanesh A, "Interrelationship of superficial siderosis and microbleeds in cerebral amyloid angiopathy", Neurology, 83, pp.1838~1843 (2014)
146. Charidimou A, "Cerebral amyloid angiopathy with and without hemorrhage: evidence for different disease phenotypes", Neurology, 84, pp.1206~1212 (2015)
147. Smith EE, "Cerebral microinfarcts: the invisible lesions", Lancet Neurol, 11, pp.272~282 (2012)
148. Brundel M, "Cerebral microinfarcts: a systematic review of neuropathological studies", J Cereb Blood Flow Metab, 32, pp.425~436 (2012)
149. van Veluw SJ, "Cortical microinfarcts on 3T MRI: clinical correlates in memory-clinic patients", Alzheimers Dement, 11, pp.1500~1509 (2015)
150. Hilal S, "Cortical cerebral microinfarcts on 3T MRI: a novel marker of cerebrovascular disease", Neurology, 87, pp.1583~1590 (2016)
151. Jouvent E, "Intracortical infarcts in small vessel disease: a combined 7-T postmortem MRI and neuropathological case study in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy", Stroke, 42, pp.e27~e30 (2011)
152. van Veluw SJ, "In vivo detection of cerebral cortical microinfarcts with high-resolution 7T MRI", J Cereb Blood Flow Metab, 33, pp.322~329 (2013)
153. van Veluw SJ, "Cerebral cortical microinfarcts at 7 Tesla MRI in patients with early Alzheimer’s disease", J Alzheimers Dis, 39, pp.163~167 (2014)
154. van Dalen JW, "Cortical microinfarcts detected in vivo on 3 Tesla MRI: clinical and radiological correlates", Stroke, 46, pp.255~257 (2015)
155. Wityk RJ, "Cerebral cortical microinfarcts on 3-t magnetic resonance imaging: a new tool in the study of cerebrovascular ischemia", JAMA Neurol, 74, pp.385~386 (2017)
156. Ii Y, "In vivo detection of cortical microinfarcts on ultrahighfield MRI", J Neuroimaging, 23, pp.28~32 (2013)
157. van Rooden S, "Increased number of microinfarcts in Alzheimer disease at 7-T MR imaging", Radiology, 270, pp.205~211 (2014)
158. Fu R, "The development of cortical microinfarcts is associated with intracranial atherosclerosis: data from the Chinese intracranial atherosclerosis study", J Stroke Cerebrovasc Dis, 24, pp.2447~2454 (2015)
159. Longstreth WT Jr, "Associations between microinfarcts and other macroscopic vascular findings on neuropathologic examination in 2 databases", Alzheimer Dis Assoc Disord, 23, pp.291~294 (2009)
160. Wang LY, "Blood pressure and brain injury in older adults: findings from a community-based autopsy study", J Am Geriatr Soc, 57, pp.1975~1981 (2009)
161. Troncoso JC, "Effect of infarcts on dementia in the Baltimore longitudinal study of aging", Ann Neurol, 64, pp.168~176 (2008)
162. Hilal S, "Association between subclinical cardiac biomarkers and clinically manifest cardiac diseases with cortical cerebral microinfarcts", JAMA Neurol, 74, pp.403~410 (2017)
163. Zheng L, "Cerebral atherosclerosis is associated with cystic infarcts and microinfarcts but not Alzheimer pathologic changes", Stroke, 44, pp.2835~2841 (2013)
164. Rosman M, "Singapore Malay Eye Study: rationale and methodology of 6-year follow-up study (SiMES-2)", Clin Exp Ophthalmol, 40, pp.557~568 (2012)
165. Hilal S, "Prevalence of cognitive impairment in Chinese: epidemiology of dementia in Singapore study", J Neurol Neurosurg Psychiatry, 84, pp.686~692 (2013)
166. Brundel M, "Cerebral microvascular lesions on highresolution 7-Tesla MRI in patients with type 2 diabetes", Diabetes, 63, pp.3523~3529 (2014)
167. Pruzin JJ, "Diabetes, hemoglobin A1C, and regional Alzheimer disease and infarct pathology", Alzheimer Dis Assoc Disord, 31, pp.41~47 (2017)
168. Yassi N, "Cortical cerebral microinfarcts on 3T MRI in Alzheimer’s disease and mild cognitive impairment", Alzheimers Dement, 13(7Suppl), pp.P1378~P1379 (2017)
169. Arvanitakis Z, "Microinfarct pathology, dementia, and cognitive systems", Stroke, 42, pp.722~727 (2011)
170. Bennett DA, "Overview and findings from the religious orders study", Curr Alzheimer Res, 9, pp.628~645 (2012)
171. Bennett DA, "Overview and findings from the rush Memory and Aging Project", Curr Alzheimer Res, 9, pp.646~663 (2012)
172. Arvanitakis Z, "The relationship of cerebral vessel pathology to brain microinfarcts", Brain Pathol, 27, pp.77~85 (2017)
173. Smith EE, "Prevention of stroke in patients with silent cerebrovascular disease: a scientific statement for healthcare professionals from the American Heart Association", American Stroke Association, 2017, pp.48, e44~e71
174. Staals J, "Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden", Neurology, 83, pp.1228~1234 (2014)
175. Elisa Cuadrado-Godia, "Cerebral Small Vessel Disease: A Review Focusing on Pathophysiology, Biomarkers, and Machine Learning Strategies", 대한뇌졸중영문학회지, 20(3), pp.302~320 (2018), 대한뇌졸중학회
176. Lau KK, "Total small vessel disease score and risk of recurrent stroke: validation in 2 large cohorts", Neurology, 88, pp.2260~2267 (2017)
177. Poggesi A, "Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: a review", J Cereb Blood Flow Metab, 36, pp.72~94 (2016)
178. Gattringer T, "Serum neurofilament light is sensitive to active cerebral small vessel disease", Neurology, 89, pp.2108~2114 (2017)
179. Marco Duering, "Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden", 대한뇌졸중영문학회지, 20(2), pp.228~238 (2018), 대한뇌졸중학회
180. Markus HS, "Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities: longitudinal results of the Austrian Stroke Prevention Study", Stroke, 36, pp.1410~1414 (2005)
181. van Dijk EJ, "C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study", Circulation, 112, pp.900~905 (2005)
182. Satizabal CL, "Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study", Neurology, 78, pp.720~727 (2012)
183. Rizzi L, "C-reactive protein and cognition are unrelated to leukoaraiosis", ScientificWorldJournal, 2014, pp.121679~ (2014)
184. Schmidt R, "C-reactive protein, carotid atherosclerosis, and cerebral small-vessel disease: results of the Austrian Stroke Prevention Study", Stroke, 37, pp.2910~2916 (2006)
185. Avci AY, "High sensitivity C-reactive protein and cerebral white matter hyperintensities on magnetic resonance imaging in migraine patients", J Headache Pain, 16, pp.9~ (2015)
186. Ashjazadeh N, "Evaluation of homocysteine level as a risk factor among patients with ischemic stroke and its subtypes", Iran J Med Sci, 38, pp.233~239 (2013)
187. Dufouil C, "Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI cohort", Neurology, 56, pp.921~926 (2001)
188. Fukuda H, "Differences between treated and untreated hypertensive subjects in the extent of periventricular hyperintensities observed on brain MRI", Stroke, 26, pp.1593~1597 (1995)
189. de Leeuw FE, "Hypertension and cerebral white matter lesions in a prospective cohort study", Brain, 125, pp.765~772 (2002)
190. Firbank MJ, "Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure. Brain atrophy, WMH change and blood pressure", J Neurol, 254, pp.713~721 (2007)
191. Dufouil C, "Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy", Circulation, 112, pp.1644~1650 (2005)
192. Godin O, "Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the Three-City (3C)-Dijon Magnetic Resonance Imaging Study", Circulation, 123, pp.266~273 (2011)
193. van Middelaar T, "Effect of antihypertensive medication on cerebral small vessel disease: a systematic review and meta-analysis", Stroke, 49, pp.1531~1533 (2018)
194. Weber R, "Telmisartan on top of antihypertensive treatment does not prevent progression of cerebral white matter lesions in the prevention regimen for effectively avoiding second strokes (PRoFESS) MRI substudy", Stroke, 43, pp.2336~2342 (2012)
195. Vuorinen M, "Changes in vascular risk factors from midlife to late life and white matter lesions: a 20-year follow-up study", Dement Geriatr Cogn Disord, 31, pp.119~125 (2011)
196. Mok VC, "Effects of statins on the progression of cerebral white matter lesion: post hoc analysis of the ROCAS (Regression of Cerebral Artery Stenosis) study", J Neurol, 256, pp.750~757 (2009)
197. Xiong Y, "Prestroke statins, progression of white matter hyperintensities, and cognitive decline in stroke patients with confluent white matter hyperintensities", Neurotherapeutics, 11, pp.606~611 (2014)
198. ten Dam VH, "Effect of pravastatin on cerebral infarcts and white matter lesions", Neurology, 64, pp.1807~1809 (2005)
199. Bernick C, "Statins and cognitive function in the elderly: the Cardiovascular Health Study", Neurology, 65, pp.1388~1394 (2005)
200. Jongen C, "Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus", Diabetologia, 50, pp.1509~1516 (2007)
201. van Harten B, "Brain imaging in patients with diabetes: a systematic review", Diabetes Care, 29, pp.2539~2548 (2006)
202. Torres ER, "Physical activity and white matter hyperintensities: a systematic review of quantitative studies", Prev Med Rep, 2, pp.319~325 (2015)
203. Rha JH, "Is antiplatelet treatment effective on the progression of white matter hyperintensity?: 5 year follow up, propensity score adjusted, observational study", Neurology, 78(1 Suppl) (2012)
204. Yoon CW, "Is antiplatelet treatment effective at attenuating the progression of white matter hyperintensities?", PLoS One, 12, pp.e0176300~ (2017)
205. Qiu J, "Antiplatelet therapy, cerebral microbleeds, and intracerebral hemorrhage: a meta-analysis", Stroke, 49, pp.1751~1754 (2018)
206. Wobith M, "Predictors of new cerebral microbleeds in patients with antiplatelet drug therapy", J Stroke Cerebrovasc Dis, 25, pp.1671~1677 (2016)
207. Charidimou A, "Cerebral amyloid angiopathy, cerebral microbleeds and implications for anticoagulation decisions: the need for a balanced approach", Int J Stroke, 13, pp.117~120 (2018)

관련 논문AI추천